Rise in Prevalence of Cancer, Genetic Diseases, and Infectious Diseases to Propel Global Viral Vector & Plasmid DNA Manufacturing Market

Global Viral Vector & Plasmid DNA Manufacturing Market: Overview

• This report analyzes the current scenario and future growth prospects of the global viral vector & plasmid DNA manufacturing market
• The report provides an elaborate executive summary, which provides a snapshot of various segments of the global viral vector & plasmid DNA manufacturing market. It also provides information and data analysis of the global viral vector & plasmid DNA manufacturing market with respect to segments based on product, application, end-user, and region.
• The overview section of the report provides a detailed qualitative analysis of drivers, restraints, and opportunities that impact the global viral vector & plasmid DNA manufacturing market
• The report includes company profiles, which provide information about business strategies, product portfolios, and financials of players operating in the global viral vector & plasmid DNA manufacturing market and competition landscape of the market
• The report on the global viral vector & plasmid DNA manufacturing market offers attractiveness analysis of different segments of the market across regions
• The last section of the report comprises quantitative and qualitative analysis on market share/position of key players operating in the global viral vector & plasmid DNA manufacturing market. It analyzes key competitive strategies adopted by major market players, thereby presenting a thorough understanding of the competition scenario in the global viral vector & plasmid DNA manufacturing market.

To know the scope of our report Get a Sample on Point-of-Care Viral vector & Plasmid DNA Manufacturing Market

Global Viral Vector & Plasmid DNA Manufacturing Market: Key Segments

• In terms of type, the global viral vector & plasmid DNA manufacturing market can be classified into lentivirus, adenovirus, adeno-associated virus (AAV), plasmid DNA, and others. The plasmid DNA segment accounted for major market share in 2018.
• Increase in awareness about gene therapy and technological advancements in the production of plasmid DNA are projected to fuel the growth of the plasmid DNA segment during the forecast period
• Based on application, the global viral vector & plasmid DNA manufacturing market has been segmented into gene therapy, vaccinology, and others
• The gene therapy segment accounted for the largest market share in 2018. Growth of the segment can be attributed to rich product pipeline and increase in the number of companies manufacturing vector-based products for gene therapies.
• In terms of disease, the global viral vector & plasmid DNA manufacturing market has been categorized into genetic disorders, cancer, infectious diseases, and others
• The cancer segment accounted for the largest market share in 2018. Growth of the segment can be attributed to high prevalence of cancer and increased acceptance of gene therapy for the treatment of cancer.
• Based on end-user, the global viral vector & plasmid DNA manufacturing market has been bifurcated into biotech companies and research institutes. The biotech companies segment accounted for major market share in 2018 and the trend is projected to continue in the near future. The biotech companies segment is anticipated to witness significant growth, owing to increase in investment by biotech companies in vector-based technologies and high demand for new therapies.
• Market size and forecast for each of the segments of the global viral vector & plasmid DNA manufacturing market have been provided for the period from 2017 to 2027. The CAGRs of the segments of the global viral vector & plasmid DNA manufacturing market have also been provided for the period from 2019 to 2027, considering 2018 as the base year.

Get a glimpse of the in-depth analysis through our Report Brochure

Global Viral Vector & Plasmid DNA Manufacturing Market: Regional Outlook

• In terms of region, the global viral vector & plasmid DNA manufacturing market has been segmented into North America (U.S. and Canada), Europe (U.K., Germany, Spain, Italy, France, and Rest of Europe), Asia Pacific (China, India, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (GCC Countries, South Africa, and Rest of Middle East & Africa). Each region of the global viral vector & plasmid DNA manufacturing market has been divided into countries/sub-regions.
• The report provides size and forecast of the global viral vector & plasmid DNA manufacturing market in each region and country/sub-region for the period from 2017 to 2027. The CAGR for the market in each of these regions and countries/sub-regions has also been provided for the period from 2019 to 2027. The study also covers the market competition scenario in these regions.

Expanding operations in future? To get the perfect launch ask for a custom report